Abstract
Metabolic stability is defined as the percentage of parent compound lost over time in the presence of a metabolically active test system. For metabolic stability assays, the typical test systems are liver microsomes, liver S9, or hepatocytes (plated or suspended), depending on the goal of the assay. To determine the metabolic stability of a new chemical entity, quantification of the drug candidate from incubate supernatants is required and usually accomplished by high-performance liquid chromatography (HPLC) with mass spectrometry. This analytical approach incorporates specificity, increased sensitivity, and higher throughput via decreased method development and analysis runtime. By understanding the metabolic stability of compounds early in discovery, compounds can be ranked for further studies, and the potential for a drug candidate to fail in development as a result of pharmacokinetic reasons may be reduced. This chapter details the procedures for performing a standard metabolic stability assay and the subsequent analysis of generated incubate samples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Li, A. (2001) Screening for human ADME/TOX drug properties in drug discovery. Drug Discov. Today 6, 357–366.
Seglen, P. O. (1976) Preparation of isolated rat liver cells. Methods Cell. Biol. 13, 29–83.
LeCluyse, E. L., Bullock, P. L., Parkinson, A., and Hochman, J. H. (1996) Cultured rat hepatocytes, in Models for Assessing Drug Absorption and Metabolism, (Borchardt, R. T., et al., eds.), Plenum, New York, pp. 121–159.
Li, A. P., Lu, C., Brent, J. A., Pham, C., Fackett, A., Ruegg, C. E., et al. (1999) Cyropreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability and drug-drug interaction potential. Chem. Biol. Interact. 121, 17–35.
Easterbrook, J., Lu, C., Sakai, Y., and Li, A. P. (2001) Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab. Dispos. 29, 141–144.
Baker, T. R., Foltz, D. J., Bornes, D. M., Peng, S. X., Hu, J. K., and Grace, J. M. (1999) Multiple-compound HPLC/MS/MS assays to obtain high-throughput metabolic stability data. Paper presented at the 47th ASMS Conference on Mass Spectrometry and Allied Topics, June, Dallas, TX.
deBethizy, J. D. and Hayes, J. R. (2001) Metabolism: a determinant in toxicity, in Principles and Methods of Toxicology, 4th ed., (Hayes, A. W., ed.), Taylor & Francis, Philadelphia, pp. 77–136.
Hickman, D., Wang, J.-P., Wang, Y., and Unadkat, J. D. (1998) Evaluation of the selectivity of in-vitro probes and suitability of organic solvents for the measurements of human cytochrome P450 monooxygenase activities. Drug Metab. Disp. 26, 207–215.
Chauret, N., Gauthier, A., and Nicoll-Griffith, D. A. (1998) Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab. Disp. 26, 1–4.
Kariv, I., Rourick, R. A., Kassel, D. B., and Chung, T. D. (2002) Improvements of “hit-to-lead” optimization by integration of in vitro HTS experimental models for early determination of pharmacokinetic properties. Comb. Chem. High Throughput Screen 5, 459–472.
Mandaagere, A. K., Thompson, T. N., and Hwang, K. K. (2002) Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. J. Med. Chem. 45, 304–311.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Ackley, D.C., Rockich, K.T., Baker, T.R. (2004). Metabolic Stability Assessed by Liver Microsomes and Hepatocytes. In: Yan, Z., Caldwell, G.W. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press. https://doi.org/10.1385/1-59259-800-5:151
Download citation
DOI: https://doi.org/10.1385/1-59259-800-5:151
Publisher Name: Humana Press
Print ISBN: 978-1-58829-332-9
Online ISBN: 978-1-59259-800-7
eBook Packages: Springer Protocols